These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24131181)

  • 21. Tiotropium inhaler devices: seeking convenience when mortality is at stake?
    Mathioudakis AG; Mathioudakis GA
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):120. PubMed ID: 23025453
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD.
    Verhamme KM; Sturkenboom MC; Brusselle GG
    Eur Respir J; 2014 Jun; 43(6):1818-9. PubMed ID: 24881063
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD.
    Meyer CN
    Eur Respir J; 2014 Jun; 43(6):1816-8. PubMed ID: 24881062
    [No Abstract]   [Full Text] [Related]  

  • 24. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J; Fehér J
    Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of tiotropium.
    Cates CJ
    BMJ; 2011 Jun; 342():d2970. PubMed ID: 21672998
    [No Abstract]   [Full Text] [Related]  

  • 26. Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2006 Jan; 61(1):91. PubMed ID: 16396956
    [No Abstract]   [Full Text] [Related]  

  • 27. Bronchodilator safety in chronic obstructive pulmonary disease-reply.
    Stanbrook MB; Campitelli M; Gershon A
    JAMA Intern Med; 2014 Apr; 174(4):648. PubMed ID: 24711200
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tiotropium: new about known].
    Stepanian IE
    Ter Arkh; 2008; 80(3):82-4. PubMed ID: 18441692
    [No Abstract]   [Full Text] [Related]  

  • 29. Bronchodilator safety in chronic obstructive pulmonary disease: time to focus?
    van Dijk WD; Käyser SC
    JAMA Intern Med; 2014 Apr; 174(4):647. PubMed ID: 24711198
    [No Abstract]   [Full Text] [Related]  

  • 30. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE; Khmel'kova NG; Belin-Atarac B
    Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.
    Dong YH; Lin HH; Shau WY; Wu YC; Chang CH; Lai MS
    Thorax; 2013 Jan; 68(1):48-56. PubMed ID: 23042705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
    McIvor RA
    Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792
    [No Abstract]   [Full Text] [Related]  

  • 33. [After diagnosis 11 more years remain. COPD alarm in Europe!].
    Wepner U
    MMW Fortschr Med; 2002 Oct; 144(44):12-3. PubMed ID: 12494590
    [No Abstract]   [Full Text] [Related]  

  • 34. Tiotropium Respimat increases the risk of mortality: con.
    Bateman ED
    Eur Respir J; 2013 Sep; 42(3):590-3. PubMed ID: 24000252
    [No Abstract]   [Full Text] [Related]  

  • 35. ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide.
    Maselli DJ; Peters JI
    Ann Intern Med; 2016 Jan; 164(2):JC6. PubMed ID: 26784496
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent?
    Mathioudakis AG; Chatzimavridou-Grigoriadou V; Evangelopoulou E; Mathioudakis GA; Siafakas NM
    Pulm Pharmacol Ther; 2014 Aug; 28(2):91-7. PubMed ID: 24846455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
    Maltais F; Mahler DA; Pepin V; Nadreau E; Crater GD; Morris AN; Emmett AH; Ferro TJ
    Eur Respir J; 2013 Aug; 42(2):539-41. PubMed ID: 23904549
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of chronic obstructive pulmonary disease.
    Barr RG
    JAMA; 2004 Mar; 291(9):1066-7; author reply 1067. PubMed ID: 14996770
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.
    Hsu JY; Perng RP; Lu JY; Wu CP; Huang MS; Luh KT; Yang PC
    J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Fischer S
    Med Monatsschr Pharm; 2014 Feb; 37(2):79-80. PubMed ID: 24624613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.